Objectives: We examined the Sorin Perceval S artificial biological valve implantation techniques, and present the initial experiences in our unit.
Methods: In the last 1.5 years, 27 patients had been implanted with Sorin Perceval S biological arteficial valve due to aortic valve disease. The device was mainly used in high-risk patients, in reoperative circumstances, in cases of calcified aortic root, and in elderly patients.
Results: The valve implantation time, aortic cross clamp time is shorter, but the risk of the operation cannot be eliminated entirely, because of the high risk patients' severe comorbidities. Furthermore, we performed echocardiography in the postoperative period, which demonstrated that the valve function is excellent, the valve fitted tightly in the anulus, and there was no paravalvular leakage.
Conclusions: The Sorin Perceval S biological arteficial aortic valve is safe to use in high risk patients, and the surgical procedure is easier in case of partial sternotomy, too.
Keywords: Sorin Perceval S; TAVI (transcatheter aortic valve implantation); TAVI – Transcatheter Aortic Valve Implantation; aortabillentyű-beültetés; aortic valve implantation; parciális sternotomia; partial sternotomy.